Overview
Status
Active
Registry date
2016-12-05
Share capital
5,000.00 PLN
Registered address
ul. Tadeusza Kościuszki 95/2u, 50-442 Wrocław, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 42 days late).
- 202519/06/2026
- 202423/06/2025
- 202308/07/2024
- 202210/05/2023
- 202126/08/2022
- 202001/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 22.94kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 6.66kMedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 16.28kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 32.61kMedianUSD 543.65kAverageUSD 1.76m
Industry
Authorized Representatives
Tomasz Jan Pacan – President of the Management Board
Urszula Maria Pacan – Vice President of the Management Board
Manner of representation
To make declarations of will on behalf of the company, in the case of a one-person management board, the President of the Management Board is authorised, and in the case of a multi-member management board, each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Urszula Maria Pacanage 77 | 90 | $1,215.56 | 90% |
Others | 10 | $135.06 | 10% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Specjalmed Isp. z o.o. | $211,310.64 | specjalmed.pl | ||
| Dukla-Medsp. z o.o. | $141,357.89 | duklamed.pl | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| RED Pharma Laboratories Central Europe Eastsp. z o.o. | $44,616.98 | red-pharma.com | ||
| Pharmer Polskasp. z o.o. | $15,884.06 | punktapteczny.online | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl |
FAQ
The main business activity of TOP-Pharma focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on December 5, 2016.
The headquarters is located at: ul. Tadeusza Kościuszki 95, 50-442 Wrocław.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 22,938 in 2025, which is a decrease of 11.3% compared to 2024.
Yes, the company recorded a net profit of USD 6,663 in 2025, meaning the company decreased its profit by 57.4%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 15,068 in 2025, representing 93% of all operating expenses.
Last updated: 2026-10-21